• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 09/26/2023
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that a versacross connect was selected for use during a watchman procedure.No heparin was given to the patient prior to the procedure.A transseptal puncture was completed, a non-boston scientific pigtail catheter (cook) was advanced on the versacross rf wire and the versacross rf wire was removed.Then, a full dose of heparin was given to the patient, and at the same time a thrombus was noticed on the non-boston scientific pigtail catheter.Therefore, the physician chose to remove the non-boston scientific pigtail catheter, flush/clean it, re-inserted it, the fxd curve sheath was aspirated, procedure continued and then was completed.Only one radio frequency was applied in the procedure.No difficulties with completing the transseptal were reported.The generator rf setting was at 1:1.It was also reported that it was the first time that the physician using versa cross connect, and his protocol was to give heparin after transseptal.It seems that the physician did not believe that the versacross devices had contributed to the clot exactly, however the speed at which it got him transeptal without the need to exchange sheaths and give heparin time to work was what caused it.There had been no act drawn or heparin given prior to the procedure.No issues with the versacross devices were reported.The devices are not expected to be returned for analysis (disposed).The imagining used was transesophageal echocardiogram (tee).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key17985363
MDR Text Key326271649
Report Number2124215-2023-58283
Device Sequence Number1
Product Code DRE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/26/2023
Initial Date FDA Received10/23/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age82 YR
Patient SexMale
-
-